<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-IIZH3BKZ</identifier><date>2021</date><creator>Čelofiga, Andreja</creator><creator>Smogavc, Žan</creator><relation>documents/doc/I/URN_NBN_SI_doc-IIZH3BKZ_001.pdf</relation><relation>documents/doc/I/URN_NBN_SI_doc-IIZH3BKZ_001.txt</relation><relation>documents/doc/I/URN_NBN_SI_DOC-IIZH3BKZ_002.pdf</relation><relation>documents/doc/I/URN_NBN_SI_DOC-IIZH3BKZ_002.txt</relation><format format_type="issue">9/10</format><format format_type="volume">90</format><format format_type="type">article</format><format format_type="extent">str. 550-558</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">85747715</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-IIZH3BKZ</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="eng">coronavirus SARS-CoV-2</subject><subject language_type_id="eng">drug-drug interaction</subject><subject language_type_id="slv">duševne motnje</subject><subject language_type_id="slv">interakcije med zdravili</subject><subject language_type_id="slv">koronavirusi</subject><subject language_type_id="eng">mental disorders</subject><subject language_type_id="slv">psihiatrična zdravila</subject><subject language_type_id="eng">psychopathological symptoms</subject><subject language_type_id="eng">psychotropic drugs</subject><subject language_type_id="slv">SARS-CoV-2</subject><title>Izzivi pri predpisovanju psihofarmakoterapije bolnikom s covidom-19</title><title>Psychotropic medication challenges in patients with COVID-19</title></Record>